文献速递头颈外科

拉丁美洲和欧洲人乳头状瘤病毒(HPV)驱动头颈癌的生物标志物研究:研究设计与HPV DNA/p16INK4a状态

Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16INK4a status.
PubMed 文献 · Head Neck · 2021-11-02

该研究在阿根廷、巴西、哥伦比亚和秘鲁的福尔马林固定石蜡包埋头颈鳞状细胞癌中评估HPV DNA和p16INK4a,采用PCR杂交进行HPV基因分型,并对所有HPV DNA阳性和部分阴性病例行p16INK4a免疫组化。结果显示口咽癌HPV DNA检出率为32.8%,口腔癌为11.1%,喉癌为17.8%;口咽癌HPV患病率在哥伦比亚为94.7%、阿根廷为42.6%,高于巴西的10.6%和秘鲁的0.0%。

要点

  • 口咽癌HPV DNA检出率为32.8%,口腔癌为11.1%,喉癌为17.8%。
  • 口咽癌HPV患病率哥伦比亚94.7%、阿根廷42.6%,高于巴西10.6%和秘鲁0.0%。
  • HPV阳性口咽癌/口腔癌病例的p16INK4a阳性率高于喉癌病例。

核心结论

  • 结果支持HPV-16在部分头颈鳞状细胞癌中起作用,印证了不同国家样本的异质性,并为全球重要影响的肿瘤提供了病因学和生物标志物信息。

研究设计与样本

  • 研究纳入阿根廷、巴西、哥伦比亚和秘鲁的福尔马林固定石蜡包埋头颈鳞状细胞癌样本,采用PCR杂交进行HPV基因分型,并对所有HPV DNA阳性和部分HPV DNA阴性病例行p16INK4a免疫组化。

主要发现

  • 口咽癌、口腔癌和喉癌的HPV DNA检出率分别为32.8%、11.1%和17.8%。
  • 口咽癌HPV患病率在哥伦比亚为94.7%、阿根廷为42.6%,高于巴西的10.6%和秘鲁的0.0%。
  • HPV-16是最常检出的型别,其他HPV型别在喉癌中被发现。
  • HPV阳性口咽癌/口腔癌病例的p16INK4a阳性率高于喉癌病例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human papillomavirus (HPV)-driven head/neck squamous cell carcinomas (HNSCC) prevalence varies globally. We evaluated HPV DNA and p16INK4a in formalin fixed paraffin embedded (FFPE) HNSCC from Argentina, Brazil, Colombia, and Peru. METHODS: HPV was genotyped by PCR-hybridization. All HPV DNA positive and some HPV DNA negative cases underwent p16INK4a immunohistochemistry. RESULTS: HPV DNA was detected in 32.8%, 11.1%, and 17.8% of oropharyngeal (OPC), oral cavity (OCC) and laryngeal (LC) cancers, respectively. OPC HPV prevalence was higher in Colombia (94.7%), and Argentina (42.6%) compared to Brazil (10.6%) and Peru (0.0%). HPV-16 was the most detected. Other HPVs were found in LC. Higher rates of p16INK4a positivity were observed among HPV positive OPC/OCC cases compared to LC cases. CONCLUSIONS: Our results support a role for HPV-16 in a subset of HNSCC, corroborate the heterogeneity observed in samples from different countries, and contribute additional etiological and biomarkers information in tumors of significant impact worldwide.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Sichero L, Tagliabue M, Mota G, et al. Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16INK4a status. Head Neck. 2021. PMID: 34726297. doi:10.1002/hed.26912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。